Amgen, Inc. (AMGN)
317.23
+3.38
(+1.08%)
USD |
NASDAQ |
Dec 10, 14:56
Amgen Free Cash Flow: 11.54B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.262B |
| Gilead Sciences, Inc. | 9.162B |
| Johnson & Johnson | 20.46B |
| Eli Lilly & Co. | 6.436B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.684B |
| Cash from Investing (Quarterly) | -414.00M |
| Cash from Financing (Quarterly) | -2.853B |
| Free Cash Flow Per Share (Quarterly) | 7.838 |
| Free Cash Flow to Equity (Quarterly) | 5.865B |
| Free Cash Flow to Firm (Quarterly) | 4.820B |
| Free Cash Flow Yield | 6.72% |